FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1196.93.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.93/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93 |
| Version | 20190510 |
| Status | active |
| Date | 2019-05-10T01:00:56-04:00 |
| Name | CPICRxNORMAbacavirSCDG |
| Title | CPIC RxNORM abacavir SCDG |
| Realm | us |
| Authority | hl7 |
| Description | We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are are seen with systemically administered medications. Elimu OID: 2019.05.13.10.35 |
| Purpose | (Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having abacavir as an ingredient),(Data Element Scope: 'None'),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having abacavir as an ingredient),(Exclusion Criteria: 'None) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1196.93",
"meta": {
"versionId": "8",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Elimu Informatics Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-10"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2019-05-10"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1196.93"
}
],
"version": "20190510",
"name": "CPICRxNORMAbacavirSCDG",
"title": "CPIC RxNORM abacavir SCDG",
"status": "active",
"experimental": false,
"date": "2019-05-10T01:00:56-04:00",
"publisher": "Elimu Informatics Steward",
"description": "We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are are seen with systemically administered medications.\nElimu OID: 2019.05.13.10.35",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having abacavir as an ingredient),(Data Element Scope: 'None'),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having abacavir as an ingredient),(Exclusion Criteria: 'None)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1163058",
"display": "abacavir / Lamivudine / Zidovudine Oral Product"
},
{
"code": "1163059",
"display": "abacavir / Lamivudine / Zidovudine Pill"
},
{
"code": "1163060",
"display": "abacavir / Lamivudine Oral Product"
},
{
"code": "1163061",
"display": "abacavir / Lamivudine Pill"
},
{
"code": "1163062",
"display": "abacavir Oral Liquid Product"
},
{
"code": "1163063",
"display": "abacavir Oral Product"
},
{
"code": "1163064",
"display": "abacavir Pill"
},
{
"code": "1546884",
"display": "abacavir / dolutegravir / Lamivudine Oral Product"
},
{
"code": "1546885",
"display": "abacavir / dolutegravir / Lamivudine Pill"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:5503f657-1f85-4507-bb0f-9cae9978b8b8",
"timestamp": "2025-05-23T19:14:05-04:00",
"total": 9,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1163058",
"display": "abacavir / lamivudine / zidovudine Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1163059",
"display": "abacavir / lamivudine / zidovudine Pill"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1163060",
"display": "abacavir / lamivudine Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1163061",
"display": "abacavir / lamivudine Pill"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1163062",
"display": "abacavir Oral Liquid Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1163063",
"display": "abacavir Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1163064",
"display": "abacavir Pill"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1546884",
"display": "abacavir / dolutegravir / lamivudine Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1546885",
"display": "abacavir / dolutegravir / lamivudine Pill"
}
]
}
}